Development of early life gut resistome and mobilome across gestational ages and microbiota-modifying treatments.

EBioMedicine

Host-Microbe Interaction Research Group, Department of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway; Paediatric Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway; Center for New Antibacterial Strategies, UiT The Arctic University of Norway, Tromsø, Norway. Electronic address:

Published: June 2023

AI Article Synopsis

  • Gestational age (GA) significantly influences the gut microbiota of preterm infants, with factors like antibiotics and probiotics also playing crucial roles in shaping this microbiome.
  • A study analyzed gut microbiota from various preterm and full-term infants, finding that GA and length of hospital stay were key predictors for microbiota development.
  • Probiotics helped to align the gut microbiota of extremely preterm infants closer to that of term infants, while antibiotic treatments increased the presence of mobile genetic elements linked to antibiotic resistance.

Article Abstract

Background: Gestational age (GA) and associated level of gastrointestinal tract maturation are major factors driving the initial gut microbiota composition in preterm infants. Besides, compared to term infants, premature infants often receive antibiotics to treat infections and probiotics to restore optimal gut microbiota. How GA, antibiotics, and probiotics modulate the microbiota's core characteristics, gut resistome and mobilome, remains nascent.

Methods: We analysed metagenomic data from a longitudinal observational study in six Norwegian neonatal intensive care units to describe the bacterial microbiota of infants of varying GA and receiving different treatments. The cohort consisted of probiotic-supplemented and antibiotic-exposed extremely preterm infants (n = 29), antibiotic-exposed very preterm (n = 25), antibiotic-unexposed very preterm (n = 8), and antibiotic-unexposed full-term (n = 10) infants. The stool samples were collected on days of life 7, 28, 120, and 365, and DNA extraction was followed by shotgun metagenome sequencing and bioinformatical analysis.

Findings: The top predictors of microbiota maturation were hospitalisation length and GA. Probiotic administration rendered the gut microbiota and resistome of extremely preterm infants more alike to term infants on day 7 and ameliorated GA-driven loss of microbiota interconnectivity and stability. GA, hospitalisation, and both microbiota-modifying treatments (antibiotics and probiotics) contributed to an elevated carriage of mobile genetic elements in preterm infants compared to term controls. Finally, Escherichia coli was associated with the highest number of antibiotic-resistance genes, followed by Klebsiella pneumoniae and Klebsiella aerogenes.

Interpretation: Prolonged hospitalisation, antibiotics, and probiotic intervention contribute to dynamic alterations in resistome and mobilome, gut microbiota characteristics relevant to infection risk.

Funding: Odd-Berg Group, Northern Norway Regional Health Authority.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192547PMC
http://dx.doi.org/10.1016/j.ebiom.2023.104613DOI Listing

Publication Analysis

Top Keywords

gut microbiota
16
preterm infants
16
resistome mobilome
12
infants
9
gut resistome
8
microbiota-modifying treatments
8
infants compared
8
compared term
8
term infants
8
antibiotics probiotics
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!